Five Tufts Faculty Named to List of Top Researchers in the World
Five current Tufts researchers have been named to the Clarivate 2022 list of the world’s most highly cited researchers. The researchers in the list “are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers,” according to Clarivate, an information and analytics firm focused on research.
The highly cited papers rank in the top 1% by citations for a field or fields and publication year, and only about 1 in 1,000 researchers worldwide qualify.
Named to the list are David Kaplan, Andrew Levey, Renata Micha, Dariush Mozaffarian, and John Wong. “These individuals are helping to transform human ingenuity into our world’s greatest breakthroughs,” said David Pendlebury, head of research analysis at the Institute for Scientific Information at Clarivate.
Also included as a top-cited researcher was Maria Flytzani-Stephanopoulos, a Tufts professor who died in 2019.
For this year’s analysis, the papers surveyed were the most recent available—those published and cited during 2011 to 2021.
“Having our faculty being among the top-cited researchers worldwide is an honor, and a welcome recognition of their ground-breaking work,” said Bernard Arulanandam, vice provost for research at Tufts. “I want to congratulate each of them for this achievement.”
Andrew Levey is a professor of medicine and Dr. Gerald J. and Dorothy R. Friedman Professor of Medicine emeritus at Tufts University School of Medicine and chief emeritus of the William B. Schwartz Division of Nephrology at Tufts Medical Center. He is involved with research groups at Tufts and around the world studying ways to gauge kidney function and better understand the burden of chronic kidney disease.
He has been honored by the U.S. National Kidney Foundation and the European Renal Association for his lifetime of dedication to the treatment of kidney diseases. In 2013 he was named the recipient of the American Society of Nephrology’s Belding H. Scribner Award, presented to individuals who have made outstanding contributions that have had a direct impact on the care of patients with kidney disease.
John B. Wong is a professor of medicine at Tufts University School of Medicine and vice chair for academic affairs and chief of the Division of Clinical Decision Making at Tufts Medical Center. He is also the director of comparative effectiveness research at the Tufts Clinical and Translational Science Institute.
His research focuses on the application of decision analysis to help patients, physicians, and policymakers choose among alternative tests, treatments, and policies. The aim is to promote rational, evidence-based, efficient, and effective patient-centered care. He has served on many national and international committees, including ones for the World Health Organization, Centers for Disease Control and Prevention, National Academy of Medicine, and U.S. Preventive Services Task Force.